Enzo Biochem Inc. ($0.01 Par Value) (NYSE: ENZ) stock closed at 1.36 per share at the end of the most recent trading day (a 0.74% change compared to the prior day closing price) with a volume of 38.93K shares and market capitalization of 67.54M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 448 people. Enzo Biochem Inc. ($0.01 Par Value) CEO is Elazar Rabbani.

The one-year performance of Enzo Biochem Inc. ($0.01 Par Value) stock is -41.81%, while year-to-date (YTD) performance is -4.9%. ENZ stock has a five-year performance of -64.95%. Its 52-week range is between 1 and 2.74, which gives ENZ stock a 52-week price range ratio of 20.69%

Enzo Biochem Inc. ($0.01 Par Value) currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 1.52, a price-to-sale (PS) ratio of 0.71, a price to cashflow ratio of 397.10, a PEG ratio of -, a ROA of -29.91%, a ROC of -34.75% and a ROE of -52.06%. The company’s profit margin is -27.31%, its EBITDA margin is -21.10%, and its revenue ttm is $98.83 Million , which makes it $2.03 revenue per share.

Of the last four earnings reports from Enzo Biochem Inc. ($0.01 Par Value), there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Enzo Biochem Inc. ($0.01 Par Value)’s next earnings report date is 13th Oct 2023.

The consensus rating of Wall Street analysts for Enzo Biochem Inc. ($0.01 Par Value) is — (0), with a target price of $12, which is +782.35% compared to the current price. The earnings rating for Enzo Biochem Inc. ($0.01 Par Value) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Enzo Biochem Inc. ($0.01 Par Value) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Enzo Biochem Inc. ($0.01 Par Value) has a Sell technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 0.06, CCI20 : -65.88, Chaikin Money Flow : -0.44, MACD : -0.04, Money Flow Index : 54.61, ROC : 3.85, RSI : 38.53, STOCH (14,3) : 25.00, STOCH RSI : 0.00, UO : 31.39, Williams %R : -75.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Enzo Biochem Inc. ($0.01 Par Value) in the last 12-months were: Hamid Erfanian (Buy at a value of $197 000), James G. Wolf (Buy at a value of $144 740)